The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Allergic Reactions vs Wegovy: What You Need to Know
Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only weight loss injections used in the UK, and serious allergic reactions to either medication are uncommon. However, understanding the differences in how these medications work, their trial safety data, and individual risk factors can help you and your prescriber make an informed decision. This guide compares allergic reaction profiles between the two, drawing on clinical evidence and UK prescribing guidance.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Clinical Trial Data and Allergic Reaction Profiles
Serious allergic reactions (anaphylaxis) to both Mounjaro and Wegovy are rare in clinical trials, though mild allergic responses such as injection site reactions are more common. In the SURMOUNT-1 trial for Mounjaro (tirzepatide), serious adverse events including hypersensitivity were reported in a small percentage of participants — fewer than 1% experienced signs of severe allergic reaction. Similarly, the STEP trials for Wegovy (semaglutide) reported hypersensitivity reactions in less than 1% of participants.
The key difference lies in their mechanism of action: Mounjaro is a dual GIP and GLP-1 receptor agonist, while Wegovy is a GLP-1 agonist only. This dual mechanism in Mounjaro theoretically means it interacts with more hormone pathways, though clinical data shows no significant difference in allergic reaction rates between the two medications. Both are administered as once-weekly injections via a pre-filled KwikPen or auto-injection pen.
- Mounjaro (tirzepatide): dual GIP + GLP-1 agonist, doses 2.5 mg to 15 mg weekly
- Wegovy (semaglutide): GLP-1 agonist only, doses 0.25 mg to 2.4 mg weekly
- Serious allergic reactions: less than 1% in both clinical trials
- Injection site reactions (mild): more common, typically resolve within days
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Who Is at Higher Risk and Prescriber Assessment
Allergic reaction risk is assessed during your clinical consultation before either medication is prescribed. Your prescriber will ask about previous reactions to GLP-1 medications, tirzepatide, semaglutide, or any other injectable medicines. If you have a history of serious allergies or anaphylaxis to any medication, inform your prescriber immediately — this may affect suitability.
Individual suitability depends on your complete medical history, not just allergic reaction risk. Your prescriber will consider other factors including blood sugar control, kidney function, and whether you have had pancreatitis. Signs that require urgent medical attention include facial swelling, throat tightness, difficulty breathing, or severe rash — these warrant emergency care regardless of which medication you are using. Both Mounjaro and Wegovy require an initial assessment and ongoing monitoring, available through NHS specialist services or private prescribing with a UK-licensed prescriber.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Are allergic reactions more common with Mounjaro or Wegovy?
Serious allergic reactions are rare with both medications, affecting less than 1% of clinical trial participants. Mild injection site reactions (redness, bruising) are more common but typically temporary. Individual risk varies based on personal allergy history, which your prescriber will assess before prescribing.
What are the signs of a serious allergic reaction to a weight loss injection?
Seek emergency medical attention immediately if you experience facial or throat swelling, difficulty breathing, severe rash, chest tightness, or dizziness. These symptoms require urgent care regardless of which GLP-1 medication you use. Always inform emergency staff which medication you have recently injected.
Can I switch from Mounjaro to Wegovy if I have an allergic reaction?
Switching between medications must always be managed by your prescriber, not independently. If you experience signs of allergy to one medication, contact your GP or prescriber immediately. They may suggest stopping the current medication and potentially switching to an alternative, with appropriate monitoring.
Do I need to declare an allergy to other medications when starting Mounjaro or Wegovy?
Yes, always declare all previous medication allergies and adverse reactions during your clinical assessment. This includes reactions to other injectable medicines, GLP-1 medications, or the specific active ingredients (tirzepatide or semaglutide). Full disclosure helps your prescriber assess your suitability safely.
What happens if I have a mild allergic reaction like injection site redness?
Mild injection site reactions (redness, itching, small bruises) are common and usually resolve within a few days. Rotate your injection site each week to minimise irritation. Contact your prescriber if redness persists beyond one week, spreads, or worsens — this may warrant assessment.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.